Header Logo

Connection

SANJEEV VASUDEVAN to Liver Neoplasms

Back to Details
This is a "connection" page, showing publications SANJEEV VASUDEVAN has written about Liver Neoplasms.
SANJEEV VASUDEVAN
Connection Strength
5.700
Liver Neoplasms
  1. A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 04; 80(4):610-621.
    View in: PubMed
    Score: 0.404
  2. Critical elements of pediatric liver cancer surgery. Semin Pediatr Surg. 2023 Oct; 32(5):151340.
    View in: PubMed
    Score: 0.400
  3. Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy. Cancer Med. 2023 12; 12(23):21270-21278.
    View in: PubMed
    Score: 0.399
  4. Surgical Management and Outcomes of Patients with Multifocal Hepatoblastoma. J Pediatr Surg. 2023 Sep; 58(9):1715-1726.
    View in: PubMed
    Score: 0.385
  5. HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
    View in: PubMed
    Score: 0.368
  6. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731. J Pediatr Surg. 2022 Oct; 57(10):251-256.
    View in: PubMed
    Score: 0.361
  7. Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction. J Pediatr Surg. 2022 Aug; 57(8):1544-1553.
    View in: PubMed
    Score: 0.340
  8. Pathologic correlation with near infrared-indocyanine green guided surgery for pediatric liver cancer. J Pediatr Surg. 2022 Apr; 57(4):700-710.
    View in: PubMed
    Score: 0.334
  9. Targeting LRH-1 in hepatoblastoma cell lines causes decreased proliferation. Oncol Rep. 2019 Jan; 41(1):143-153.
    View in: PubMed
    Score: 0.281
  10. Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg. 2017 Jun; 52(6):956-961.
    View in: PubMed
    Score: 0.251
  11. Characteristics and outcomes in children with undifferentiated embryonal sarcoma of the liver: A report from the National Cancer Database. Pediatr Blood Cancer. 2017 04; 64(4).
    View in: PubMed
    Score: 0.245
  12. Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy. J Pediatr Surg. 2016 Apr; 51(4):525-9.
    View in: PubMed
    Score: 0.228
  13. Intraoperative ultrasound for liver tumor resection in children. J Surg Res. 2015 Oct; 198(2):418-23.
    View in: PubMed
    Score: 0.220
  14. Teratoid Hepatoblastoma: Clinicopathologic Features and Outcomes. Pediatr Blood Cancer. 2025 Oct; 72(10):e31903.
    View in: PubMed
    Score: 0.112
  15. The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience. Pediatr Blood Cancer. 2024 Nov; 71(11):e31214.
    View in: PubMed
    Score: 0.105
  16. Surgical management of liver tumors. Pediatr Blood Cancer. 2025 Apr; 72 Suppl 2:e31155.
    View in: PubMed
    Score: 0.104
  17. An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer. Hepatol Commun. 2024 06 01; 8(6).
    View in: PubMed
    Score: 0.103
  18. Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332. Cancer. 2024 Aug 01; 130(15):2683-2693.
    View in: PubMed
    Score: 0.102
  19. Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study. Pediatr Blood Cancer. 2024 Jun; 71(6):e30975.
    View in: PubMed
    Score: 0.102
  20. Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs). Pathol Res Pract. 2024 Mar; 255:155163.
    View in: PubMed
    Score: 0.101
  21. A population-based assessment of metastatic hepatoblastoma in Texas reveals ethnic disparities. Front Public Health. 2023; 11:1049727.
    View in: PubMed
    Score: 0.095
  22. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022 10; 77(4):1026-1037.
    View in: PubMed
    Score: 0.090
  23. Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study. Cancer. 2022 07 15; 128(14):2786-2795.
    View in: PubMed
    Score: 0.090
  24. Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma. J Pediatr Hematol Oncol. 2021 Nov 01; 43(8):e1181-e1185.
    View in: PubMed
    Score: 0.087
  25. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
    View in: PubMed
    Score: 0.082
  26. Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. Pediatr Blood Cancer. 2019 07; 66(7):e27745.
    View in: PubMed
    Score: 0.073
  27. Clinically significant ascites as an indication for resection of rapidly involuting congenital hepatic hemangiomas. Pediatr Blood Cancer. 2018 08; 65(8):e27222.
    View in: PubMed
    Score: 0.068
  28. Undifferentiated Embryonal Sarcoma of the Liver (UESL): A Single-Center Experience and Review of the Literature. J Pediatr Hematol Oncol. 2016 05; 38(4):261-8.
    View in: PubMed
    Score: 0.059
  29. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
    View in: PubMed
    Score: 0.059
  30. Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging. Pediatr Radiol. 2014 Oct; 44(10):1275-80.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.